期刊文献+

MicroRNA-93在骨肉瘤组织中的表达及其意义 被引量:2

Expression and Significance of MicroRNA-93 in Osteosarcoma
在线阅读 下载PDF
导出
摘要 目的:分析MicroRNA-93(miR-93)在骨肉瘤组织中的表达,探讨其对骨肉瘤细胞的增殖及细胞周期的影响。方法:采用TagManMGB探针法定量分析38例骨肉瘤组织及对应软骨组织中miR-93的表达;构建miR-93过表达载体,并合成miR-93的反义核苷酸序列,分别转染骨肉瘤细胞U2-OS和MG-63。采用MTT比色法检测骨肉瘤细胞增殖的改变情况,利用流式细胞仪检测骨肉瘤细胞周期的变化情况。结果:在38例骨肉瘤标本中,65.8%(25/38)的骨肉瘤组织miR-93表达明显高于对应软骨组织(P<0.05)。miR-93过表达载体可以促进骨肉瘤细胞的生长,使细胞周期G0/G1期明显降低,而S期比例明显增加;反义miR-93转染骨肉瘤细胞U2-OS和MG-63后,miR-93的表达明显降低,U2-OS和MG-63骨肉瘤细胞生长受到明显抑制,其生长主要停滞在G0/G1期,而S期和G2/M期细胞的比例下降。结论:miR-93在骨肉瘤组织中表达明显上调,其可以通过调节细胞周期中G1/S期的转换而影响骨肉瘤细胞生长。 Objective: To analyze the expression of microRNA-93 (miR-93) in osteosarcoma and to investigate the effect of miR-93 on the proliferation and cell cycle in osteosarcoma cell lines. Methods: TagMan MGB real-time PCR was used to detect the expression of miR-93 in 38 pairs of osteosarcoma and cartilaginous tissues. The over-expressed vector of miR-93 was constructed, and the miR-93 antisense nucleotide sequence was synthesized. Then they were transfected into osteosareoma cell lines U2-OS and MG-63. The cell proliferation was detected by MTF assay and cell cycle was detected by flow cytometry. Results: The 65.8% (25/38)of miR-93 was over expressed in osteosarcoma compared to cartilaginous tissues (P 〈 0.05). The over expression of miR-93 could promote the growth of osteosarcoma cell line and delay the cell cycle in S phase. The reduction of miR-93 could inhibit the growth of osteosarcoma cell line and delay the cell cycle in G0/G1 phase. Conclusion: miR-93 was over expressed in osteosarcoma and could regulate the growth of osteosarcoma cells via mediating the transition of G1/S phase, which may become a target gene of osteosarcoma.
出处 《天津医药》 CAS 北大核心 2012年第12期1218-1221,共4页 Tianjin Medical Journal
关键词 骨肉瘤 微RNAS 细胞增殖 细胞周期 转染 microRNA-93 osteosarcoma microRNAs cell proliferation cell cycle transfection miR-93
作者简介 通讯作者:高志增,E-mail:690737188@qq.com
  • 相关文献

参考文献14

  • 1Canale ST, Beaty JH. Campbell's Operative Orthopaedics[M]. llth edition, Mosby/Elsevier, 2008:901-902.
  • 2Yu DC, Li QG, Ding XW, et al. Circulating microRNAs: potential biomarkers for cancer[J]. Int J Mol Sci, 2011, 12(3): 2055-2063.
  • 3Sayed D, Abdellatif M. MicroRNAs in development and disease[J]. Physiol Rev, 2011, 91(3): 827-887.
  • 4Croce CM. Causes and consequences of microRNA dysregulation in cancer[J]. Nat Rev Genet, 2009, 10(10):704-714.
  • 5Munker R, Calin GA. MicroRNA profiling in cancer [J]. Clin Sci (Lond), 2011, 121(4): 141-158.
  • 6Zhong X, Coukos G, Zhang L. miRNAs in human cancer [J]. Methods Mol Biol, 2012, 822:295-306.
  • 7Wang X, Tang S, Le SY,et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth[J].PLoS One, 2008, 3(7): e2557.
  • 8Nikifomva MN,Tseng GC,Steward D,et al.MicroRNA expression profiling of thyroid tumors:biological significance and diagnostic utility[J].J Clin Endocrinol Metab, 2008, 93(5): 1600-1608.
  • 9Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers[J]. Mol Cancer, 2007, 6: 60.
  • 10Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues[J]. Oncogene, 2006, 25(17):2537-2545.

同被引文献45

  • 1Ritter J,Bielack SS. Osteosarcoma[J].Ann 0ncol,2010, 21(Suppl 7):320-325.
  • 2Dalerha F,Oylla SJ,Park IK,et al. Phenotypic charac- terization of human colorectal cancer stem cells[J]. Proc Nail Acad Sci USA,2007,104(21):10158-10163.
  • 3Yin S,Li J,Hu C,et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorige- nicity[J].Int J Cancer,2007,120(7):1444-1450.
  • 4Monzani E,Facchetti F,Galmozzi E,et al. Melanoma contains CD133 and ABCG2 positive ceils with enha- nced tumorigenic potential [J].Eur J Cancer. 2007, 43(5):935-946.
  • 5Pan J,Mestas J,Burdick MD, et al. Stromal derived factor-l(SDF-1/CXCL12)and CXCR4 in renal cell carci- noma metastasis[J].Mol Cancer,2006,38(5):56.
  • 6Kawada K,Hosoqi H,Sonoshita M, et al. Chemokine recep- tor CXCR3 promotes colon cancer metastasis to lymph- nodes[J].Oncogene,2007,26(32):4679-4688.
  • 7Murakami Y,Yasuda T, Saigo K,et al. Comprehensive analysis of microRNA expression patterns in hepato- cellular carcinoma and non-tumorous tissues [J]. Oncogene,2006,25(17):2537-2545.
  • 8Fang L,Deng Z,Shatseva T,et al. MicroRNA miR-93 pro- motes tumor growth and angiogenesis by targeting integrin-~8[J].Oncogene,2011,30(7):806-821.
  • 9Osaki M,Takeshita F,Suimoto Y,et al. Micro-RNA-143 regulates human osteosarcoma metastasis by regula- ting matrix metalloprotease-13 expression [J].Mol Yher,2011,19(6):1123-1130.
  • 10Zhang H,Cai X, Wang Y,et al. micro RNA-143,down regu-lated in ostesarcoma,promoters apoptosis and supp- resses tumorigenicity by targeting Bcl-2[J].Oncol Rep,2010,24(5):1363-1369.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部